Changchang Lu
- Oncology top 10%
- Immunology top 10%
- Molecular Biology
- Cancer Research
- Pulmonary and Respiratory Medicine
- Topics
- Pancreatic and Hepatic Oncology Research (8 papers)Cancer Immunotherapy and Biomarkers (7 papers)Immunotherapy and Immune Responses (6 papers)
- Cited by
- ImmunologyOncologyCancer Research
- Journals
- SHILAP Revista de lepidopterologíaBiomaterialsFrontiers in Immunology
In The Last Decade
Changchang Lu
19 papers receiving 444 citations
Peers
Comparison fields: 5 of 59
- Oncology 260
- Immunology 247
- Molecular Biology 131
- Cancer Research 74
- Pulmonary and Respiratory Medicine 58
Countries citing papers authored by Changchang Lu
This map shows the geographic impact of Changchang Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changchang Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changchang Lu more than expected).
Fields of papers citing papers by Changchang Lu
This network shows the impact of papers produced by Changchang Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changchang Lu. The network helps show where Changchang Lu may publish in the future.
Co-authorship network of co-authors of Changchang Lu
This figure shows the co-authorship network connecting the top 25 collaborators of Changchang Lu. A scholar is included among the top collaborators of Changchang Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changchang Lu. Changchang Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 4 | |
| 3 | 1 | |
| 4 | 3 | |
| 5 | 16 | |
| 6 | 8 | |
| 7 | 16 | |
| 8 | 9 | |
| 9 | 3 | |
| 10 | 0 | |
| 11 | 4 | |
| 12 | 2 | |
| 13 | 5 | |
| 14 | 2 | |
| 15 | 106 | |
| 16 | 55 | |
| 17 | 172 | |
| 18 | Advanced Lung Cancer Is Associated with Decreased Expression of Perforin, CD95, CD38 by Circulating CD3+CD8+ T Lymphocytes. | 9 |
| 19 | 11 | |
| 20 | 19 |
About Changchang Lu
Changchang Lu is a scholar working on Immunology, Oncology and Biotechnology, having authored 20 papers that have together received 448 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (8 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Immunotherapy and Immune Responses (6 papers). The work is most often cited by research in Immunology (247 citations), Oncology (260 citations) and Cancer Research (74 citations). Changchang Lu has collaborated with scholars based in China and India. Frequent co-authors include Liyun Xu, Yanyan Huang, Dongdong Chen, Xiaoguang Liu, Jian-Ying He, Yongkui Zhang, Guoqing Wu, Wei Yu, Hanbo Le and Xuetian Yue. Their work appears in journals such as SHILAP Revista de lepidopterología, Biomaterials and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.